Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) usersDAUMANN, Jörg; SCHNITKER, Ralph; WEIDEMANN, Jürgen et al.Neuroreport (Oxford). 2003, Vol 14, Num 15, pp 1983-1987, issn 0959-4965, 5 p.Article

Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine)PIZARRO, Nieves; FARRE, Magi; PUJADAS, Mitona et al.Drug metabolism and disposition. 2004, Vol 32, Num 9, pp 1001-1007, issn 0090-9556, 7 p.Article

EcstasySEIDLE, Raymond.Current therapeutics. 2001, Vol 42, Num 3, pp 92-93, issn 0311-905XArticle

Chronic MDMA (ecstasy) use, cognition and moodMCCARDLE, K; LUEBBERS, S; CARTER, J. D et al.Psychopharmacologia. 2004, Vol 173, Num 3-4, pp 434-439, issn 0033-3158, 6 p.Article

MDMA (ECSTACY) : Useful information for health professionals involved in drug education programsELK, C.Journal of drug education. 1996, Vol 26, Num 4, pp 349-356, issn 0047-2379Article

Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humansKIRKPATRICK, Matthew G; FRANCIS, Sunday M; LEE, Royce et al.Psychoneuroendocrinology. 2014, Vol 46, pp 23-31, issn 0306-4530, 9 p.Article

Proton magnetic resonance spectroscopy in ecstasy (MDMA) usersDAUMANN, Jörg; FISCHERMANN, Thomas; PILATUS, Ulrich et al.Neuroscience letters. 2004, Vol 362, Num 2, pp 113-116, issn 0304-3940, 4 p.Article

Decreased pain tolerance and mood in recreational users of MDMAO'REGAN, Margaret Claire; CLOW, Angela.Psychopharmacologia. 2004, Vol 173, Num 3-4, pp 446-451, issn 0033-3158, 6 p.Article

Ecstasy: Commodity or disease?AGAR, Michael; REISINGER, Heather Schacht.Journal of psychoactive drugs. 2004, Vol 36, Num 2, pp 253-264, issn 0279-1072, 12 p.Article

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanismsLYLES, Johnalyn; CADET, Jean Lud.Brain research reviews. 2003, Vol 42, Num 2, pp 155-168, issn 0165-0173, 14 p.Article

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administrationDUMONT, G. J. H; SWEEP, F. C. G. J; VAN DER STEEN, R et al.Social neuroscience (Print). 2009, Vol 4, Num 4, pp 359-366, issn 1747-0919, 8 p.Article

Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine AdministrationKOLBRICH, Erin A; GOODWIN, Robert S; GORELICK, David A et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 4, pp 432-440, issn 0271-0749, 9 p.Article

MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor functionKUYPERS, K. P. C; SAMYN, N; RAMAEKERS, J. G et al.Psychopharmacologia. 2006, Vol 187, Num 4, pp 467-475, issn 0033-3158, 9 p.Article

Quels sont les effets recherchés et les effets secondaires de la drogue «ectasy»? = Ecstasy : biological effectsGARNIER, R.Concours médical (Paris). 1995, Vol 117, Num 29, pp 2211-2212, issn 0010-5309Article

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine (Ectasy)MCGUIRE, P. K; COPE, H; FAHY, T. A et al.British journal of psychiatry (Print). 1994, Vol 165, Num SEP, pp 391-395, issn 0007-1250Article

The effects of stereotype threat on cognitive function in ecstasy usersCOLE, J. C; MICHAILIDOU, K; JEROME, L et al.Journal of psychopharmacology (Oxford). 2006, Vol 20, Num 4, pp 518-525, issn 0269-8811, 8 p.Article

L'influence du groupe des pairs sur les usages de droguesBOHRN, K; FENK, R.PSYCHOTROPES. 2003, Vol 9, Num 3-4, pp 195-202, issn 1245-2092, 8 p.Article

Nouvelles drogues, nouveaux usages : le cas de l'ecstasyCOSTES, Jean-Michel.Actualité et dossier en santé publique. 2001, Num 37, pp 13-16, issn 1243-275XArticle

Effects of Acute 3, 4-Methylenedioxymethamphetamine on Sleep and Daytime Sleepiness in MDMA Users: A Preliminary StudyRANDALL, Surilla; JOHANSON, Chris-Ellyn; TANCER, Manuel et al.Sleep (New York, NY). 2009, Vol 32, Num 11, pp 1513-1519, issn 0161-8105, 7 p.Article

Patterns of memory dysfunction in current and 2-year abstinent MDMA usersWARD, Jeff; HALL, Kate; HASLAM, Catherine et al.Neuropsychology, development, and cognition. Section A, journal of clinical and experimental neuropsychology. 2006, Vol 28, Num 3, pp 306-324, issn 1380-3395, 19 p.Article

Putting an ecstasy test Kit to the test: Harm reduction or harm induction?MURRAY, Rebecca A; DOERING, Paul L; BOOTHBY, Lisa A et al.Pharmacotherapy. 2003, Vol 23, Num 10, pp 1238-1244, issn 0277-0008, 7 p.Article

Subacute effects of ecstasy on mood: an exploration of associated risk factorsSCOTT, Rebecca M; HIDES, Leanne; ALLEN, J. Sabura et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 1, pp 53-61, issn 0269-8811, 9 p.Article

3 cases of primary intracranial hemorrhage associated with Molly, a purified form of 3,4-methylenedioxymethamphetamine (MDMA)KAHN, D. Ethan; FERRARO, Nicholas; BENVENISTE, Ronald J et al.Journal of the neurological sciences. 2012, Vol 323, Num 1-2, pp 257-260, issn 0022-510X, 4 p.Article

The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-GlucuronidesSCHWANINGER, Andrea E; MEYER, Markus R; ZAPP, Josef et al.Drug metabolism and disposition. 2009, Vol 37, Num 11, pp 2212-2220, issn 0090-9556, 9 p.Article

Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethanphetamine (MDMA) under acidic conditionsYAMAUCHI, Yosuke; IZUMI, Takaya; UNEMURA, Kazuhiro et al.Neuroscience letters. 2007, Vol 428, Num 2-3, pp 72-76, issn 0304-3940, 5 p.Article